Jump to main content
Jump to site search

Issue 111, 2016, Issue in Progress
Previous Article Next Article

4-Thiazolidinone derivatives: synthesis, antimicrobial, anticancer evaluation and QSAR studies

Author affiliations

Abstract

A series of 4-thiazolidinone derivatives (1–18) was synthesized and tested in vitro for its antimicrobial and anticancer potential. Synthesized compounds were found to be 5 more potent antimicrobial agents than anticancer agents. Anticancer screening results indicated that compound 13 (IC50 = 15.18 μM) was the most active anticancer agent and was more potent than the standard drug, carboplatin (IC50 > 100 μM). Antimicrobial activity results indicated that 14 was the most active antimicrobial agent (pMICec = 2.14 μM) and may serve as an important lead for the discovery of novel antimicrobial agents. The QSAR studies indicated that the antibacterial and antifungal activities of the synthesized derivatives against different microbial strains were governed by lipophilic parameter, log P, topological parameter, κα3 and electronic parameters cos E and Nu. E.

Graphical abstract: 4-Thiazolidinone derivatives: synthesis, antimicrobial, anticancer evaluation and QSAR studies

Back to tab navigation

Publication details

The article was received on 15 Sep 2016, accepted on 08 Nov 2016 and first published on 09 Nov 2016


Article type: Paper
DOI: 10.1039/C6RA23006G
Citation: RSC Adv., 2016,6, 109485-109494
  •   Request permissions

    4-Thiazolidinone derivatives: synthesis, antimicrobial, anticancer evaluation and QSAR studies

    A. Deep, B. Narasimhan, S. M. Lim, K. Ramasamy, R. K. Mishra and V. Mani, RSC Adv., 2016, 6, 109485
    DOI: 10.1039/C6RA23006G

Search articles by author

Spotlight

Advertisements